Court Upholds Relmada Therapeutics against Laidlaw

Recently Nevada courts decided in favor of Relmada Therapeutics to issue a temporary restraining order and associated injunction against Laidlaw & Company. Laidlaw’s principles, Matthes Eitner and James Ahern were specifically called out for dispersing false information. Laidlaw has a history of customer complaints against them for violating U.S. financial regulations. I believe they were trying to take over the business to pull profits out of the company as it is growing. Relmada didn’t want this to happen for fear of long term impact to the business.

I think it was smart of Relmada to take these precautions to control their own destiny. Laidlaw sounds shady when dealing with companies and probably have their own interest at stake. Spreading false information in order to obtain something they desire is not the right way to go. I assume long term relationships are now spent from this deal. Hopefully, Relmada did not need financing help from Laidlaw & Company.

Laidlaw is located in the United Kingdom and provides investment banking and wealth management. Its clients are located in the United States or the United Kingdom. Also, it provides skillful advice and experience to individuals and institutions. Advisory services also include acquisitions, divestitures, and restructurings. If only they would follow the regulations as needed this company would be excellent.

No Comments (yet)

Leave a Reply

Comments RSS Subscribe to the Comments RSS.